tirzepatide cardiovascular outcomes trial results july 2025 Matches Dulaglutide in Large CV Trial: SURPASS-CVOT A 72-week trial compared the
Description
Although it is designed to reduce inflammation related to diabetes, the changes it causes in the immune system or metabolism may have side effects for some people
Front Med (Lausanne)
These benefits were still apparent and even larger for some conditions a year later, and tirzepatide users were also less likely to die of any cause
[ 4 ] In practical terms
Antecedentes personales o familiares de carcinoma medular de tiroides (un tipo de cncer de tiroides)
